A Multilevel Approach for Improvement in Screening of Colorectal Cancer in Rural Communities, The Screen to Save Trial

Sponsor
Fred Hutchinson Cancer Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05291988
Collaborator
(none)
100
2
1
24
50
63.4

Study Details

Study Description

Brief Summary

This clinical trial determines the feasibility of a multilevel approach to improve colorectal cancer screening within two rural regions of the Fred Hutchinson Cancer Research Center/University of Washington Consortium catchment area. The catchment area is the greater Puget Sound Region (13 counties). These rural counties have the highest overall rates of cancer incidence and mortality in the area; rural/small town residents in the catchment area had the lowest rates of meeting mammogram, Pap, and colorectal screening recommendations. This study involves observational data and questionnaire assessments to determine if an online version of the evidence-informed national colorectal cancer screening program, known as "Screen to Save (S2S)" and a fecal immunochemical test (FIT) kit distribution are acceptable and accessible to patients. FIT kits may help doctors find colorectal cancer sooner, when it may be easier to treat.

Condition or Disease Intervention/Treatment Phase
  • Other: Educational Intervention
  • Other: Fecal Immunochemical Test
  • Other: Questionnaire Administration
N/A

Detailed Description

OUTLINE:

Participants receive S2S online screening education and FIT kit for sample collection.

After completion of study intervention, patients are followed up at 3 months.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
A Multilevel Approach to Improving Colorectal Cancer Screening in Rural Communities of the FH/UW Catchment Area
Anticipated Study Start Date :
Aug 6, 2022
Anticipated Primary Completion Date :
Aug 30, 2022
Anticipated Study Completion Date :
Aug 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Screening (S2S education, FIT kit)

Participants receive S2S online screening education and FIT kit for sample collection.

Other: Educational Intervention
Receive S2S education
Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational
  • Other: Fecal Immunochemical Test
    Receive FIT kit
    Other Names:
  • FIT
  • iFOBT
  • immunoassay fecal occult blood test
  • immunochemical fecal occult blood test
  • Immunochemical FOBT
  • immunologic fecal occult blood test
  • Other: Questionnaire Administration
    Ancillary Studies

    Outcome Measures

    Primary Outcome Measures

    1. Accessibility [Up to 3 months]

      Three questions will be asked post-intervention to assess fit of the screen to save (S2S) education, suitability, and usefulness of the useful for learning about colorectal cancer (CRC) and CRC screening.

    2. Acceptability [Up to 3 months]

      Four questions will be asked post-intervention to assess approval, appeal, whether the participant liked, or welcomed the S2S education.

    3. Participant uptake [Up to 3 months]

      Feasibility evaluation will include assessment of the number of participants that respond to the letter of invitation to 1) participate in the educational portion of the project by viewing the online S2S education and completing the online questionnaires and 2) complete the pick-up and return of the FIT Kit. This will be assessed through participant tracking and follow-up procedures.

    4. Demographic information [At pre-intervention only]

      The following demographic information will be collected: participant's age, gender, race/ethnicity, preferred language, household income, highest level of education, insurance status, ZIP code, country of origin, and years of United States (U.S.) residence. Demographics will be analyzed within each group using Chi-square or Fisher's exact test for paired binary data.

    Secondary Outcome Measures

    1. Colorectal cancer knowledge [Up to 3 months]

      Knowledge will be assessed pre- and post-intervention. The knowledge scale will include 5 multiple choice knowledge questions about colorectal screening and colorectal cancer presented as part of the S2S inflatable colon education.

    2. Behavioral intention [Up to 3 months]

      Intention to get CRC screening will be assessed using one question with a 5-point response option (1 = Very Unlikely, 2 = Somewhat Unlikely, 3 = Neutral, 4 = Somewhat Likely, 5 = Very Likely).

    3. Social engagement [Up to 3 months]

      Social engagement likelihood will be measure using a single question about their intention to share information learned during the S2S education with others (parents, grandparents, relatives, peers, community members).

    4. Medical and colorectal cancer information [At pre-intervention]

      Use of regular health clinic and medical providers, history of colorectal cancer screening, and family and personal history of colorectal cancer diagnosis.

    5. COVID-19 impact assessment [At pre-intervention]

      A single question about the impact of COVID-19 on the decision to get colorectal cancer screening will determine if non-adherence was related to COVID-19. A yes/no response will be required.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Age 45 years or older or < 45 years old with family history of CRC

    • Speak and read English or Spanish

    • Current resident in Clallam county

    • Currently non-adherent to CRC screening recommendations

    Exclusion Criteria:
    • Age < 18 years old

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Fred Hutch/University of Washington Cancer Consortium Seattle Washington United States 98109
    2 Olympic Medical Cancer Care Center Sequim Washington United States 98384

    Sponsors and Collaborators

    • Fred Hutchinson Cancer Center

    Investigators

    • Principal Investigator: Rachel Ceballos, Fred Hutch/University of Washington Cancer Consortium

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Fred Hutchinson Cancer Center
    ClinicalTrials.gov Identifier:
    NCT05291988
    Other Study ID Numbers:
    • RG1121686
    • NCI-2022-01172
    First Posted:
    Mar 23, 2022
    Last Update Posted:
    Jul 7, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 7, 2022